Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.995 USD | +5.00% | +5.50% | -32.61% |
Mar. 25 | Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol | DJ |
Mar. 25 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.61% | 360M | |
+25.85% | 661B | |
+26.74% | 566B | |
-6.65% | 352B | |
+19.49% | 332B | |
+3.55% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.46% | 145B |
- Stock Market
- Equities
- ESPR Stock
- News Esperion Therapeutics, Inc.
- Transcript : Esperion Therapeutics, Inc., Q4 2023 Earnings Call, Feb 27, 2024